Substance / Medication

Capreomycin

Overview

Active Ingredient
capreomycin
RxNorm CUI
78903

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

2 trials linked to this intervention

2
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Investigation of drug regimens and treatment outcome in patients with: a systematic review.
Dashtbin Shirin, Mirkalantari Shiva, Dadashi Masoud et al. · Expert Rev Anti Infect Ther · 2022
PMID: 35306950Meta-Analysis
The global outbreak of Mycobacterium chimaera infections in cardiac surgery-a systematic review of whole-genome sequencing studies and joint analysis.
Schreiber Peter W, Kohl Thomas A, Kuster Stefan P et al. · Clin Microbiol Infect · 2021
PMID: 34298175Meta-Analysis
Medical Tourism and Postoperative Infections: A Systematic Literature Review of Causative Organisms and Empiric Treatment.
Padilla Pablo, Ly Priscilla, Dillard Rachel et al. · Plast Reconstr Surg · 2018
PMID: 30489537Meta-Analysis
Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
Mao Xiaolu, Ke Zunqiong, Shi Xiaoyan et al. · Ann Clin Lab Sci · 2015
PMID: 26586705Meta-Analysis
Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis.
Dharmadhikari Ashwin S, Kabadi Mohan, Gerety Bob et al. · Antimicrob Agents Chemother · 2013
PMID: 23529740TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Capreomycin (substance)
SNOMED CT
387081001
UMLS CUI
C0262964
RxNorm CUI
78903

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.